Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in

Status Recruiting

Clinical Trial Summary

Dysphagia is an important complication in patients with medullary infarction, the incidence rate is 57%-69%. Compared with other brain infarctions, the medulla oblongata involves multiple swallowing-related nerve nuclei, and the possibility of brain remodeling after injury is small. Dysphagia has become a prominent clinical problem in patients with medullary infarction, which can lead to malnutrition, decrease the quality of life of patients and affect the prognosis of the disease. Solving this clinical problem is particularly important for patients with medullary infarction. The incidence of UES opening disorder in patients with medullary infarction is as high as 80%, and the clinical problem of UES opening disorder is enthusiastically studied at home and abroad. At present, the intervention measures include balloon dilatation, surgical incision and botulinum toxin injection. Balloon dilatation is easy to cause mucosal edema and damage, and cricopharyngeal myotomy often has complications such as local infection, massive hemorrhage and local nerve injury. There is no significant difference between the success rate of UES botulinum toxin injection and surgical incision. Among the above measures, UES botulinum toxin injection has a good clinical application prospect, but the drug dosage and injection method are still not unified in clinic. In particular, how to accurately locate has become a hot topic in current research. On this basis, this study uses ultrasound combined with balloon localization to inject UES botulinum toxin and make clinical observation.

Clinical Trial Description

Under the ultrasound combined with balloon fixation, two injection sites were selected from the left upper esophageal sphincter, and 30U was injected respectively, and one injection site was selected from the right side, and 30U was injected. In addition, the patient also received routine swallowing training once a day for 30 minutes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06196606
Study type	Interventional
Source	The First Affiliated Hospital of Zhengzhou University
Contact	Yuli Zhu, postgraduate
Phone	+8615351370521
Email	15351370521@163.com
Status	Recruiting
Phase	N/A
Start date	November 11, 2022
Completion date	December 12, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04064333` - Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care	N/A
Completed	`NCT03649295` - Combined Conventional Speech Therapy and Functional Electrical Stimulation in Dysphagia Following Stroke	N/A
Terminated	`NCT03167892` - Oral Screens in Post Stroke Training	N/A
Recruiting	`NCT06072924` - K01 Impacts of Lingual Endurance Exercise	N/A
Enrolling by invitation	`NCT05497219` - Reference Values for Videofluoroscopic Measures of Swallowing	N/A
Completed	`NCT03676582` - AspiRATE: Novel Intervention to Acoustically Detect Silent Aspiration in Acquired Dysphagia.
Completed	`NCT02973698` - Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients	N/A
Recruiting	`NCT05862792` - Liposomal Bupivacaine and Transoral Robotic Surgery
Completed	`NCT04465903` - Validity and Reliability of the Turkish Version of the Sydney Swallow Questionnaire
Recruiting	`NCT05865483` - Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)
Completed	`NCT03790956` - Silk Protein Microparticle-based Filler for Injection Augmentation	N/A
Completed	`NCT03499574` - Feasibility Study of Biofeedback in Dysphagia Therapy Post Stroke	N/A
Completed	`NCT04344392` - Screening of Dysphagia Via Ultrasonography in Patients With Stroke	N/A
Completed	`NCT04305860` - Acceptance of Different Thickeners in Dysphagia	N/A
Recruiting	`NCT05935618` - Occupational Therapy Rehabilitation for Frail Elders With Dysphagia	N/A
Recruiting	`NCT04565587` - Dose-response Effect of the Thickener Tsururinko Quickly	N/A
Recruiting	`NCT04398862` - Pulmonary Health in Children With Down Syndrome
Not yet recruiting	`NCT06369337` - Ultrasound Study of the Submentonian Musculature and Its Relationship in Dysphagia

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms